3/21/2012 6:35:27 AM
INDIANAPOLIS & ZÜRICH--(BUSINESS WIRE)--Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), and Dualsystems Biotech announced today, a drug profiling agreement. Under the agreement, Dualsystems Biotech will use its drug profiling platform to identify molecular targets for an undisclosed small molecule lead candidate in Dow AgroSciences’ agrochemical discovery program. Dualsystems Biotech as a partner will contribute to the identification of new targets and elucidation of the mechanism of action of a novel class of compounds.
comments powered by